Sections

Home | Eyes and Vision

Eyes and Vision

Macular Degeneration Insight Identifies Promising Drugs to Prevent Vision Loss

In a study published this week in the Proceedings of the National Academy of Sciences, a University of Wisconsin-Madison research team pinpoints ...

Why apnea patients are prone to suffer from glaucoma

Scientists at Hokkaido University have successfully measured the eye pressure of sleeping patients with obstructive sleep apnea syndrome for the first time, ...

Clinical trial tests cord-blood cells to treat macular degeneration

UIC is part of a national phase 2 clinical trial to evaluate the safety and tolerability of using cells derived from multipotent umbilical cord cells to treat age-related macular degeneration, the most common cause of vision loss in people over 55. ... Full story

Study suggests humans can detect even the smallest units of light

Just how dark does it have to be before our eyes stop working? Research by a team from Rockefeller University and the Research Institute of Molecular Pathology in Austria has shown that humans can detect the presence of a single photon, the smallest measurable unit of light. Previous studies had established that human subjects acclimated to the dark were capable only of reporting flashes of five to seven photons. ... Full story

FDA approves first intraocular lens with extended range of vision for cataract patients

The U.S. Food and Drug Administration today approved the first intraocular lens (IOL) that provides cataract patients with an extended depth-of-focus, which helps improve their sharpness of vision (visual acuity) at near, intermediate and far distances. ... Full story

Simple procedure could improve treatment for common eye disease

Rejuvenating the cornea could reduce the need for cornea transplants ... Full story

FDA approves new medication for dry eye disease

The U.S. Food and Drug Administration approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease, on Monday, July 11, 2016. Xiidra is the first medication in a new class of drugs, called lymphocyte function-associated antigen 1 (LFA-1) agonist, approved by the FDA for dry eye disease. ... Full story

First-ever restoration of vision achieved in mice

Broken links between retinal ganglion cells and target structures throughout the brain spell permanent vision loss. But in a new study, these long-distance connections — and partial vision — were restored. ... Full story

Successful mimicking the development of the whole eye with human iPS cells

Prospects for development of new techniques in regenerative medicine to treat intractable corneal disease ... Full story

FDA approves implantable device that changes the shape of the cornea to correct near vision

The U.S. Food and Drug Administration today approved the Raindrop Near Vision Inlay, a device implanted in the cornea (the clear, front surface) of one eye to improve near vision in certain patients with presbyopia. It is the second FDA-approved implantable corneal device for correction of near vision in patients who have not had cataract surgery and the first implantable device that changes the shape of the cornea to achieve improved vision. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 819 | displaying: 1 - 10